X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (428) 428
oncology (352) 352
female (223) 223
male (205) 205
lung neoplasms - pathology (201) 201
lung cancer (195) 195
lung neoplasms - genetics (184) 184
middle aged (156) 156
cancer (151) 151
aged (144) 144
expression (115) 115
mutation (108) 108
lung neoplasms - metabolism (106) 106
adult (104) 104
carcinoma, non-small-cell lung - genetics (103) 103
prognosis (102) 102
cell line, tumor (100) 100
immunohistochemistry (100) 100
tumors (100) 100
animals (99) 99
carcinoma, non-small-cell lung - pathology (98) 98
mice (88) 88
pathology (86) 86
adenocarcinoma (85) 85
respiratory system (84) 84
gene expression regulation, neoplastic (78) 78
carcinoma (77) 77
lung neoplasms - drug therapy (76) 76
adenocarcinoma - pathology (74) 74
adenocarcinoma - genetics (73) 73
aged, 80 and over (73) 73
survival (71) 71
gene expression (60) 60
carcinoma, non-small-cell lung - metabolism (58) 58
mutations (57) 57
neoplasm staging (57) 57
genetic aspects (52) 52
respiratory tract diseases (52) 52
lung neoplasms - mortality (51) 51
carcinoma, non-small-cell lung - drug therapy (50) 50
cell biology (50) 50
research (46) 46
breast-cancer (42) 42
activation (40) 40
adenocarcinoma - metabolism (40) 40
analysis (40) 40
gene (40) 40
disease-free survival (39) 39
apoptosis (38) 38
loss of heterozygosity (38) 38
metastasis (38) 38
signal transduction (38) 38
carcinoma, non-small-cell lung - mortality (37) 37
chemotherapy (37) 37
polymerase chain reaction (37) 37
immunotherapy (36) 36
proteins (36) 36
abridged index medicus (35) 35
carcinoma, squamous cell - genetics (35) 35
care and treatment (35) 35
biomarkers, tumor - genetics (34) 34
cell lung-cancer (34) 34
carcinoma, squamous cell - pathology (33) 33
gene expression profiling (33) 33
kaplan-meier estimate (33) 33
non-small cell lung cancer (33) 33
treatment outcome (33) 33
multidisciplinary sciences (32) 32
nsclc (32) 32
egfr (31) 31
growth-factor receptor (31) 31
health aspects (31) 31
identification (31) 31
therapy (31) 31
cell proliferation (30) 30
gefitinib (30) 30
genes (30) 30
lung cancer, non-small cell (30) 30
survival analysis (30) 30
adenocarcinoma of lung (29) 29
cells (29) 29
lung-cancer (29) 29
pathogenesis (29) 29
biomarkers (28) 28
gene-expression (28) 28
receptor, epidermal growth factor - genetics (28) 28
biomarkers, tumor - analysis (27) 27
dna methylation (27) 27
patients (27) 27
sensitivity (26) 26
tumor cells, cultured (26) 26
biochemistry & molecular biology (25) 25
biomarkers, tumor - metabolism (25) 25
classification (25) 25
development and progression (25) 25
epithelial-mesenchymal transition (25) 25
lung adenocarcinoma (25) 25
medicine (25) 25
pulmonary and respiratory medicine (25) 25
retrospective studies (25) 25
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of thoracic oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S116 - S118
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S172 - S172
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 12, pp. 2081 - 2090
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 4, p. e34833
... I. Nunez Affiliation: The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America Ignacio I. Wistuba Affiliation: The University... 
FUS1 PROTEIN | DNA COMPLEXES | LIPOSOME | ADENOVIRUS VECTOR | HOMOZYGOUS DELETION REGION | TUMOR-SUPPRESSOR GENES | BIOLOGY | LUNG-CANCER CELLS | HUMAN-CHROMOSOME 3P21.3 | EXPRESSION | P53 | Lung Neoplasms - genetics | Gene Transfer Techniques | Lung Neoplasms - drug therapy | Tumor Suppressor Proteins - metabolism | Tumor Suppressor Proteins - administration & dosage | Tumor Suppressor Proteins - therapeutic use | Apoptosis - drug effects | Fatty Acids, Monounsaturated - administration & dosage | Humans | Apoptosis - genetics | Gene Expression Profiling | Positron-Emission Tomography | Reverse Transcriptase Polymerase Chain Reaction | Dose-Response Relationship, Drug | Maximum Tolerated Dose | Nanoparticles - therapeutic use | Quaternary Ammonium Compounds - administration & dosage | Nanoparticles - administration & dosage | Plasmids - administration & dosage | Genetic Therapy - methods | Medical colleges | PET imaging | Lung cancer | Genes | Clinical trials | Metastasis | Gene expression | Nanoparticles | Cytokinins | Chemotherapy | Messenger RNA | Gene therapy | Cancer | Apoptosis | Intravenous administration | Emission analysis | Correlation coefficients | Staining | Lipids | Dosage | Tissues | Cancer therapies | Metabolic response | Anticancer properties | Metastases | Genetic abnormalities | Platinum | Protein folding | Chlorides | Peripheral blood | Trimethylammonium chloride | Tomography | Pretreatment | Deoxyribonucleic acid--DNA | Correlation coefficient | Enzymes | Abnormalities | Positron emission | Patients | Vectors (Biology) | Cholesterol | Polymerase chain reaction | Biopsy | Adenoviruses | Quality control | Tumor suppressor genes | Mutation | Positron emission tomography | Tumors | Deoxyribonucleic acid | DNA
Journal Article
Nature (London), ISSN 1476-4687, 2010, Volume 467, Issue 7318, pp. 986 - 990
Aberrant expression of microRNAs (miRNAs) and the enzymes that control their processing have been reported in multiple biological processes including primary... 
MUTANT | LI-FRAUMENI-SYNDROME | MULTIDISCIPLINARY SCIENCES | P63 EXPRESSION | MICE | CANCER | P73 | CARCINOMA | PROGRESSION | P53 | FAMILY | Genomic Instability | Endoribonucleases - genetics | Humans | Transcriptional Activation | Gene Expression Regulation, Neoplastic | Male | MicroRNAs - metabolism | Phosphoproteins - metabolism | Promoter Regions, Genetic - genetics | DEAD-box RNA Helicases - biosynthesis | Neoplasms - genetics | Cellular Senescence | Tumor Suppressor Proteins - deficiency | DEAD-box RNA Helicases - deficiency | Genes, Tumor Suppressor - physiology | Tumor Suppressor Proteins - genetics | Trans-Activators - genetics | Female | DEAD-box RNA Helicases - metabolism | Cell Line | Neoplasms - secretion | Tumor Suppressor Proteins - metabolism | Ribonuclease III - genetics | Ribonuclease III - metabolism | Endoribonucleases - metabolism | Mice, Inbred C57BL | MicroRNAs - biosynthesis | Phosphoproteins - genetics | Ribonuclease III - biosynthesis | Ribonuclease III - deficiency | DEAD-box RNA Helicases - genetics | Neoplasm Metastasis - genetics | Animals | Trans-Activators - deficiency | Phosphoproteins - deficiency | Cell Line, Tumor | Trans-Activators - metabolism | Mice | MicroRNAs - genetics | Transcription Factors | Neoplasms - pathology | Care and treatment | MicroRNA | Tumor suppressor genes | Genetic aspects | Metastasis | Research | Health aspects | Risk factors | Genotype & phenotype | Medical research | Binding sites | Tumors
Journal Article
Hematology/oncology clinics of North America, ISSN 0889-8588, 02/2017, Volume 31, Issue 1, pp. 13 - 29
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2016, Volume 113, Issue 11, pp. E1555 - E1564
Journal Article
Clinical cancer research, ISSN 1078-0432, 03/2018, Volume 24, Issue 5, pp. 1038 - 1047
Journal Article